title: Developing a case study model for successful translation of stem cell therapies.
abstract: Cell therapies derived from pluripotent stem cells are entering the preclinical and early clinical development phase, but eventual translation faces many challenges. We describe a new approach by California to form global public-private "disease team" partnerships to enable new clinical opportunities to be evaluated in the complex regulatory environment.
authors.affiliation: California Institute for Regenerative Medicine, San Francisco, CA 94107, USA. atrounson@cirm.ca.gov
authors.forename: Alan
authors.initials: A
authors.lastname: Trounson
authors.forename: Elona
authors.initials: E
authors.lastname: Baum
authors.forename: Don
authors.initials: D
authors.lastname: Gibbons
authors.forename: Patricia
authors.initials: P
authors.lastname: Tekamp-Olson
mesh_terms: D002140:California; D064987:Cell- and Tissue-Based Therapy / Q000191:economics; D002986:Clinical Trials as Topic; D006801:Humans; D007348:Insurance, Health; D007883:Legislation, Medical; D017059:Models, Econometric; D019982:Organizational Case Studies; D039904:Pluripotent Stem Cells; D055818:Public-Private Sector Partnerships; D012109:Research Support as Topic; D057170:Translational Research, Biomedical